ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
AllanHU
|
183 |
94K |
10 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
AllanHU
|
13K |
5.0M |
22 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
AllanHU
|
13K |
5.0M |
4 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
AllanHU
|
317 |
157K |
10 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
317
|
157K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
AllanHU
|
317 |
157K |
2 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
317
|
157K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
AllanHU
|
317 |
157K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
317
|
157K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
AllanHU
|
317 |
157K |
20 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
317
|
157K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
AllanHU
|
1.0K |
419K |
8 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
419K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
3 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
97
|
249K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
1 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
97
|
249K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
7 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
97
|
249K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
9 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
97
|
249K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
5 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
97
|
249K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PNV 4 New Patents
|
|
AllanHU
|
81 |
31K |
5 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
81
|
31K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Update
|
|
AllanHU
|
140 |
58K |
2 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
140
|
58K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Update
|
|
AllanHU
|
140 |
58K |
5 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
140
|
58K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
3 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
97
|
249K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
9 |
23/02/20 |
23/02/20 |
ASX - By Stock
|
97
|
249K
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
7 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
13 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
23K
|
13M
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
22 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
23K
|
13M
|
22
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
8 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
12 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
31 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
23K
|
13M
|
31
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
28 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
23K
|
13M
|
28
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
AllanHU
|
888 |
645K |
4 |
22/01/20 |
22/01/20 |
Charts
|
888
|
645K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AllanHU
|
23K |
13M |
5 |
07/01/20 |
07/01/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Files GvHD Clinical Efficacy and Safety Data with US FDA
|
|
AllanHU
|
73 |
49K |
7 |
03/01/20 |
03/01/20 |
ASX - By Stock
|
73
|
49K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Files GvHD Clinical Efficacy and Safety Data with US FDA
|
|
AllanHU
|
73 |
49K |
15 |
03/01/20 |
03/01/20 |
ASX - By Stock
|
73
|
49K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
10 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
2 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
AllanHU
|
275 |
160K |
6 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
275
|
160K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Newsletter - Chronic Low Back Pain
|
|
AllanHU
|
9 |
7.1K |
1 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
9
|
7.1K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Newsletter - Chronic Low Back Pain
|
|
AllanHU
|
9 |
7.1K |
8 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
9
|
7.1K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Newsletter - Chronic Low Back Pain
|
|
AllanHU
|
9 |
7.1K |
9 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
9
|
7.1K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
5 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
3 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
8 |
22/09/19 |
22/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
AllanHU
|
17K |
6.8M |
0 |
20/09/19 |
20/09/19 |
ASX - By Stock
|
17K
|
6.8M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Fujifilm Exercises License Option in GvHD
|
|
AllanHU
|
327 |
127K |
13 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
327
|
127K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
AllanHU
|
97 |
41K |
4 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
97
|
41K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
AllanHU
|
97 |
41K |
18 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
97
|
41K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
4 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
5 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
4 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
AllanHU
|
17K |
6.8M |
7 |
14/09/19 |
14/09/19 |
ASX - By Stock
|
17K
|
6.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
AllanHU
|
4.4K |
2.4M |
6 |
13/09/19 |
13/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
AllanHU
|
162 |
84K |
13 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
162
|
84K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
AllanHU
|
162 |
84K |
4 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
162
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Circulation Research Highlights MSB Heart Failure Therapy
|
|
AllanHU
|
36 |
16K |
12 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
36
|
16K
|
12
|
|